Selective blockade of vascular endothelial growth factor receptor 2 with an antibody against tumor-derived vascular endothelial growth factor controls the growth of human pancreatic adenocarcinoma xenografts
Shane E. Holloway, Adam W. Beck, Latha Shivakumar, Jessica Shih, Jason B. Fleming, Rolf A. Brekken
Dive into the research topics of 'Selective blockade of vascular endothelial growth factor receptor 2 with an antibody against tumor-derived vascular endothelial growth factor controls the growth of human pancreatic adenocarcinoma xenografts'. Together they form a unique fingerprint.